Bank of America Corp DE Acquires 29,971 Shares of Astrana Health, Inc. (NASDAQ:ASTH)

Bank of America Corp DE raised its stake in shares of Astrana Health, Inc. (NASDAQ:ASTH - Free Report) by 44.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 97,721 shares of the company's stock after buying an additional 29,971 shares during the period. Bank of America Corp DE owned about 0.17% of Astrana Health worth $3,081,000 as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. Pilgrim Partners Asia Pte Ltd purchased a new stake in Astrana Health during the 4th quarter valued at $40,000. Quarry LP grew its position in shares of Astrana Health by 35.5% during the 4th quarter. Quarry LP now owns 1,799 shares of the company's stock valued at $57,000 after acquiring an additional 471 shares during the period. KBC Group NV grew its position in shares of Astrana Health by 108.4% during the 4th quarter. KBC Group NV now owns 2,530 shares of the company's stock valued at $80,000 after acquiring an additional 1,316 shares during the period. US Bancorp DE grew its position in shares of Astrana Health by 3,880.0% during the 4th quarter. US Bancorp DE now owns 4,776 shares of the company's stock valued at $151,000 after acquiring an additional 4,656 shares during the period. Finally, Pictet Asset Management Holding SA grew its position in shares of Astrana Health by 21.9% during the 4th quarter. Pictet Asset Management Holding SA now owns 7,075 shares of the company's stock valued at $223,000 after acquiring an additional 1,273 shares during the period. 52.77% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on ASTH shares. Bank of America cut their price objective on shares of Astrana Health from $55.00 to $49.00 and set a "buy" rating for the company in a research report on Tuesday, March 4th. Barclays started coverage on shares of Astrana Health in a research report on Tuesday, April 1st. They set an "equal weight" rating and a $36.00 price objective for the company. Robert W. Baird cut their price objective on shares of Astrana Health from $86.00 to $50.00 and set an "outperform" rating for the company in a research report on Monday, March 3rd. Truist Financial cut their price objective on shares of Astrana Health from $50.00 to $46.00 and set a "buy" rating for the company in a research report on Tuesday, March 18th. Finally, Stifel Nicolaus cut their price objective on shares of Astrana Health from $70.00 to $56.00 and set a "buy" rating for the company in a research report on Thursday, February 20th. Three investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $53.29.

Astrana Health Price Performance

ASTH stock traded down $0.29 during trading on Monday, reaching $24.50. The company's stock had a trading volume of 194,980 shares, compared to its average volume of 290,907. Astrana Health, Inc. has a 1 year low of $23.12 and a 1 year high of $63.20. The company has a quick ratio of 1.91, a current ratio of 1.91 and a debt-to-equity ratio of 0.60. The company has a market capitalization of $1.37 billion, a P/E ratio of 18.85, a price-to-earnings-growth ratio of 1.37 and a beta of 1.00. The company's fifty day moving average is $29.69 and its 200-day moving average is $33.38.

Astrana Health (NASDAQ:ASTH - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The company reported $0.14 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.23 by ($0.09). The business had revenue of $620.39 million during the quarter, compared to analysts' expectations of $628.11 million. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. The company's quarterly revenue was up 53.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.31 EPS. On average, research analysts expect that Astrana Health, Inc. will post 1.15 earnings per share for the current fiscal year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.